Warning: The NCBI web site requires JavaScript to function. more...
Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis.
Capsoni F, Sarzi-Puttini P, Atzeni F, Minonzio F, Bonara P, Doria A, Carrabba M.
Arthritis Res Ther. 2005;7(2):R250-5. Epub 2005 Jan 10.
Related citations
Neutrophil migration and production of reactive oxygen species during treatment with a fully human anti-tumor necrosis factor-alpha monoclonal antibody in patients with rheumatoid arthritis.
den Broeder AA, Wanten GJ, Oyen WJ, Naber T, van Riel PL, Barrera P.
J Rheumatol. 2003 Feb;30(2):232-7.
Neutrophils of rheumatoid arthritis patients on anti-TNF-α therapy and in disease remission present reduced adhesive functions in association with decreased circulating neutrophil-attractant chemokine levels.
Dominical VM, Bértolo MB, Almeida CB, Garrido VT, Miguel LI, Costa FF, Conran N.
Scand J Immunol. 2011 Apr;73(4):309-18. doi: 10.1111/j.1365-3083.2011.02503.x.
[Are there any positive effects of TNF-alpha blockers on bone metabolism?].
Seriolo B, Paolino S, Sulli A, Cutolo M.
Reumatismo. 2006 Jul-Sep;58(3):199-205. Italian.
[Correlation between different clinical activity and anti CC-P (anti-cyclic citrullinated peptide antibodies) titres in rheumatoid arthritis treated with three different tumor necrosis factors TNF-alpha blockers].
Benucci M, Turchini S, Parrochi P, Boccaccini P, Manetti R, Cammelli E, Manfredi M.
Recenti Prog Med. 2006 Mar;97(3):134-9. Italian.
Peripheral blood lymphocytes from patients with rheumatoid arthritis are differentially sensitive to apoptosis induced by anti-tumour necrosis factor-alpha therapy.
Coury F, Ferraro-Peyret C, Le Cam S, Guerin S, Tebib J, Sibilia J, Bienvenu J, Fabien N.
Clin Exp Rheumatol. 2008 Mar-Apr;26(2):234-9.
Oxidative burst of neutrophils in patients with rheumatoid arthritis: influence of various cytokines and medication.
Mur E, Zabernigg A, Hilbe W, Eisterer W, Halder W, Thaler J.
Clin Exp Rheumatol. 1997 May-Jun;15(3):233-7.
Induction of CD69 activation molecule on human neutrophils by GM-CSF, IFN-gamma, and IFN-alpha.
Atzeni F, Schena M, Ongari AM, Carrabba M, Bonara P, Minonzio F, Capsoni F.
Cell Immunol. 2002 Nov;220(1):20-9.
Study of eosinophil-endothelial adhesion, production of oxygen radicals and release of eosinophil cationic protein by peripheral blood eosinophils of patients with rheumatoid arthritis.
Mertens AV, De Clerck LS, Moens MM, Bridts CH, Stevens WJ.
Clin Exp Allergy. 1993 Oct;23(10):868-73.
Inhibition of neutrophil migration soon after initiation of treatment with leflunomide or methotrexate in patients with rheumatoid arthritis: findings in a prospective, randomized, double-blind clinical trial in fifteen patients.
Kraan MC, de Koster BM, Elferink JG, Post WJ, Breedveld FC, Tak PP.
Arthritis Rheum. 2000 Jul;43(7):1488-95.
Differences in annual medication costs and rates of dosage increase between tumor necrosis factor-antagonist therapies for rheumatoid arthritis in a managed care population.
Ollendorf DA, Klingman D, Hazard E, Ray S.
Clin Ther. 2009 Apr;31(4):825-35.
Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss.
Wijbrandts CA, Klaasen R, Dijkgraaf MG, Gerlag DM, van Eck-Smit BL, Tak PP.
Ann Rheum Dis. 2009 Mar;68(3):373-6. Epub 2008 Apr 13.
Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis.
Wijbrandts CA, van Leuven SI, Boom HD, Gerlag DM, Stroes EG, Kastelein JJ, Tak PP.
Ann Rheum Dis. 2009 Aug;68(8):1316-21. Epub 2008 Aug 22.
Circulating tumour necrosis factor-alpha bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response.
Marotte H, Maslinski W, Miossec P.
Arthritis Res Ther. 2005;7(1):R149-55. Epub 2004 Dec 1.
Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis.
Seriolo B, Paolino S, Sulli A, Fasciolo D, Cutolo M.
Ann N Y Acad Sci. 2006 Jun;1069:414-9.
Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis.
Van Doornum S, McColl G, Wicks IP.
Rheumatology (Oxford). 2005 Nov;44(11):1428-32. Epub 2005 Aug 2.
Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate.
Parker A, Izmailova ES, Narang J, Badola S, Le T, Roubenoff R, Ginsburg GS, Maier A, Coblyn JS, Shadick NA, Weinblatt ME.
J Rheumatol. 2007 Sep;34(9):1817-22. Epub 2007 Aug 1.
Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL, Watson KD, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register.
Rheumatology (Oxford). 2006 Dec;45(12):1558-65. Epub 2006 May 16.
Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab.
Toubi E, Kessel A, Mahmudov Z, Hallas K, Rozenbaum M, Rosner I.
Ann N Y Acad Sci. 2005 Jun;1051:506-14.
CD69 expression on neutrophils from patients with rheumatoid arthritis.
Atzeni F, Del Papa N, Sarzi-Puttini P, Bertolazzi F, Minonzio F, Capsoni F.
Clin Exp Rheumatol. 2004 May-Jun;22(3):331-4.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on